{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-121456","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.038952+00:00","generated_at":"2026-05-30T05:22:32.658282+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Treace Medical Q3 revenue $45.1M (+11%), net loss improves to ($15.4M), launches Nanoplasty MIS system","bullets":["Revenue $45.1M (+11% YoY); net loss improved to ($15.4M) or ($0.25)/share from ($17.5M) loss in Q3 2023.","Adjusted EBITDA loss narrowed 45% to ($5.1M) from ($9.2M) in Q3 2023.","First entry into osteotomy market with Nanoplasty 3D Minimally Invasive Bunion Correction system; second MIS platform planned later in Q4.","Filed patent infringement suit to protect Lapiplasty technology; patent portfolio now 67 U.S. patents.","FY2024 revenue guidance revised to $204M-$211M (was $201M-$211M); expects Adjusted EBITDA loss to halve YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-121456","json":"https://secwatch.observer/filing/0000950170-24-121456.json","markdown":"https://secwatch.observer/filing/0000950170-24-121456.md","text":"https://secwatch.observer/filing/0000950170-24-121456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000095017024121456/0000950170-24-121456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000095017024121456/tmci-20241105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:22:32.658282+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}